Pax3 Antibody (3A8) Summary
PAX3 (NP_852122 307 a.a. – 414 a.a.) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. LSETSYQPTSIPQAVSDPSSTVHRPQPLPPSTVHQSTIPSNPDSSSAYCLPSTRHGFSSYTDSFVPPSGPSNPMNPTIGNGLSPQVMGLLTNHGGVPHQPQTDYALSP
PAX3 (3A8)
IgG2b Kappa
Monoclonal
Mouse
PAX3
IgG purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Western Blot
- ELISA
Antibody reactivity against Recombinant Protein with GST tag on ELISA and WB. GST tag alone is used as a negative control.
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
PBS (pH 7.4)
No Preservative
IgG purified
Notes
Quality control test: Antibody Reactive Against Recombinant Protein.
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Pax3 Antibody (3A8)
- CDHS
- HUP2
- HUP2MGC120384
- MGC120381
- MGC120382
- MGC120383
- MGC134778
- paired box 3
- paired box gene 3 (Waardenburg syndrome 1)
- paired box homeotic gene 3
- paired box protein Pax-3
- paired domain gene 3
- paired domain gene HuP2
- Pax3
- Waardenburg syndrome 1
- WS1
- WS3
Background
This gene is a member of the paired box (PAX) family of transcription factors. Members of the PAX family typically contain a paired box domain and a paired-type homeodomain. These genes play critical roles during fetal development. Mutations in paired box gene 3 are associated with Waardenburg syndrome, craniofacial-deafness-hand syndrome, and alveolar rhabdomyosarcoma. The translocation t(2;13)(q35;q14), which represents a fusion between PAX3 and the forkhead gene, is a frequent finding in alveolar rhabdomyosarcoma. Alternative splicing results in transcripts encoding isoforms with different C-termini.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets : Haspin Kinase inhibitors